Login
Navigate Fool.com
Will DRNA beat
the market?
Community Rating: 4 Stars: Favorite

15.26 0.36 (2.42%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.77
Previous Close $14.90
Daily Range $14.36 - $15.42
52-Week Range $14.36 - $46.00
Market Cap $271.1M
P/E Ratio -0.03
Dividend (Yield) $0.00 (0.0%)
Volume 350,569
Average Daily Volume 184,311
Current FY EPS -$2.17

How do you think DRNA
will perform against the market?

Top DRNA Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted April 12, 2014

Dicerna seems to be the poster child for zzporte woes in the spring biopharma sector downturn, given that we bought 450 shares close to the highs since the February IPO and are now down well over 50%. … More

8 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

Why Dicerna Pharmaceuticals Inc Stock Skyrocketed

Is this meaningful? Or just another movement?

Sector Update: Healthcare Narrowly Lower This Afternoon; Dicerna Pharmaceuticals Surges After Early

Sector Update: Healthcare Narrowly Lower This Afternoon; Dicerna Pharmaceuticals Surges After Early Study of Liver Drug Supports Use

Sector Update: Healthcare

Monday’s Top Biotech Stories: MannKind, Dicerna, Flamel, and Merck

MannKind, Dicerna, Flamel, and Merck are the top biotech stocks to watch this Monday morning.

The harder they fall: high-popping IPOs hammered in aftermarket trading

3 Horrendous Health-Care Stocks This Week

Find out which health-care stocks ended up as the past week's worst losers.

Is Biotech in a Bubble? The Bear Case Explained

Biotech IPOs provide some powerful indications...

Candy Crush mania coming to Wall Street

Candy Crush mania coming to Wall Street

Biotechs Tripling at IPO! Sign of Biotech Bubble?

Investors are craving the risk that's offered by the IPOs of Ultragenyx Pharmaceuticals and Dicerna Pharmaceuticals.

US IPO Recap: Varonis provides data security for enterprises and financial security for investors

See More DRNA News...

Sector

Industry

DICERNA PHARMACEUTICALS INC (DRNA) Description

DICERNA PHARMACEUTICALS INC Website:

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks